Blood test could cut unnecessary drug use in critically ill
NCT ID NCT02154178
Summary
This study tested whether using blood tests for fungal biomarkers could help doctors safely stop antifungal medications sooner in critically ill ICU patients. 110 patients who started antifungal treatment were randomly assigned to have their treatment guided by biomarker results or by standard care. The goal was to reduce the duration of unnecessary antifungal therapy, which can have side effects and costs.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICU, Salengro Hospital, University Hospital of Lille
Lille, Nord, 59035, France
Conditions
Explore the condition pages connected to this study.